Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Munich CyberKnife Center Is a Pioneer in Offering Most Advanced Radiosurgical Tumor Treatment


News provided by

European CyberKnife Center Munich

01 Oct, 2015, 06:00 GMT

Share this article

Share toX

Share this article

Share toX

This image opens in the lightbox
First ten cancer treatments successfully performed with the CyberKnife(R) M6[TM] System using the new InCise[TM] 2 Multileaf Collimator (PRNewsFoto/European CyberKnife Center Munic) (PRNewsFoto/European CyberKnife Center Munic)

MUNICH, October 1, 2015 /PRNewswire/ --

First ten cancer treatments successfully performed with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator

The European CyberKnife Center Munich (ECZM) announced today that they have successfully performed their first ten treatments with the CyberKnife® M6™ System using the new InCise™ 2 Multileaf Collimator (MLC). Recently developed and officially released for clinical usage, the MLC expands the versatility of the CyberKnife System, enabling clinicians to treat a broader range of tumors in size and shape than before with significantly reduced treatment times. With the adoption of the new InCise 2 MLC, the Munich CyberKnife Center continues to provide its patients with cutting-edge treatments.  

     (Photo: http://photos.prnewswire.com/prnh/20150930/272524 )

The Munich CyberKnife Center has successfully performed their first ten treatments using the CyberKnife M6 System with the InCise 2 MLC in significantly shorter treatment times. The patients, diagnosed with liver, prostate or brain tumors, were typical candidates for radiosurgery and stereotactic body radiotherapy delivered by the CyberKnife System. "We recently treated a patient with brain metastases after lung cancer using the new InCise 2 MLC. We achieved the same sub-millimeter precision we've come to rely on with the CyberKnife System, in 20 minutes, so half the time compared to previous treatment session using another collimator. The CyberKnife treatment time included set-up, continuous imaging and the time spent delivering the radiation. This technical feature is a clear benefit to our department and to our patients", said Prof. Alexander Muacevic, who founded the Munich CyberKnife Center together with his colleague Prof. Berndt Wowra in 2005.

Over the last ten years, the ECZM has successfully performed nearly 6,000 tumor treatments. For patients, a CyberKnife treatment is painfree and convenient. Whereas conventional radiation therapy lasts several weeks and conventional surgery involves high side effects, the CyberKnife System is a safe and effective alternative for tumor treatment. A 78-year old man who had liver metastases after colorectal cancer received an outpatient CyberKnife treatment using the InCise 2 MLC to treat his large tumor volume of 70,1 cm[3]. The treatment time was 19 minutes. This is significantly shorter than the 60 minutes it would have taken with conventional fixed collimators. The new InCise 2 MLC treatment is similarly accurate and effective at sparing healthy liver tissue. After a short treatment time, patients are able to leave for home and spend the day with their families. Therefore, the CyberKnife treatment enables them to continue with their normal daily routine and helps them to maintain a good quality of life.

"I want to recognize the European CyberKnife Center Munich for its latest achievement in having successfully treated the first patients with the CyberKnife M6 System using the InCise 2 MLC," said Lionel Hadjadjeba, President of Accuray International. "The MLC is a major advancement for the CyberKnife System and this accomplishment was realized through partnering with experienced clinicians committed to enhancing the quality of care they provide to their patients."

The CyberKnife M6™ Series delivers radiosurgery enabling precise, high-quality dose distributions to be delivered to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The CyberKnife® System directs treatment beams differing in size, shape, and intensity from hundreds of non-coplanar angles around the patient. The ability to deliver more beams from more angles gives the clinician freedom to generate highly conformal dose distributions that carefully avoid healthy organs. During each treatment, the system continually collects images to track tumor motion and automatically adjusts for that motion in real-time, ensuring that clinicians deliver radiation exactly where they want it.

About the European CyberKnife Center  

The European CyberKnife Center Munich is one of the world's leading centers for radiosurgery. As Germany's first CyberKnife center it was opened in cooperation with the University Clinic Munich (LMU) on July 1, 2005. Its medical experience is based on nearly 6,000 courses of treatment since 2005. Already since 2013 the Munich center has been using the latest generation of CyberKnife technology (M6). Besides the clinical and scientific cooperation with the LMU, the Munich Center collaborates internationally with colleagues around the world. Being part of the Radiosurgery Society's (http://www.therss.org) Board of Directors the ECZM puts great efforts in the development of internationally appreciated treatment standards, education and quality control.

Download press pictures

Media Contact:

Nina von Reden
European CyberKnife Center Munich
Max Lebsche Platz 31, 81377 Munich/ Germany

Tel: +49-(0)89-452336-0
Fax: +49-(0)89-452336-16
nina.vonreden@cyber-knife.net

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.